Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-10
1998-03-03
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483731, 5483751, 5483761, 5483771, A61K 31415, A01N 4356, C07D23114
Patent
active
057234833
ABSTRACT:
The invention relates to new substituted 1-phenyl-3-pyrazolecarboxamides having a great affinity for human neurotensin receptors, to a process for preparing them and to pharmaceutical compositions containing them as active principles. More particularly, this invention relates to the discovery that the affinity for neurotensin receptors, especially human neurotensin receptors, is increased by substituting the phenyl group of 1-phenyl-3-pyrazolecarboxamide compounds with particular groups.
REFERENCES:
Data Base Crossfire, BRN=509860, & Justus Liebigs AA. Chem., vol. 120,(1861) p.126.
Database Crossfire, BRN=1841460, & J. Chem. Soc., p. 4060(1964).
Database Crossfire, BRN=3297648 & Andre `Dissertation`, (1909), Bonn p. 27.
Database Crossfire, BRN=3257569, & Auden Dissertation, (1897), Tuebingen, p 17.
"Database Crossfire, BRN=3312692," & Chem. Ber., vol. 62, (1929), p. 2566.
Database Cross Fire, BRN=1818200, & Helv. Chim. Acta, pp. 793-797, vol. 43, (1960).
Database Crossfire, BRN=910233, & Chem. Ber., vol. 21, p. 3409 (1888).
Database Crossfire, BRN=1818353, & Indian J. Chem., vol. 1, (1963), pp. 247-249.
Database Crossfire, BRN=1818417, & US-A-4 105 766 (Sterling Drug) (1978).
Database Cross Fire, BRN-1818415, & US-A-4 105 766 (Sterling Drug) (1978).
Database Crossfire, BRN=1819156, & Chem Ber., vol., 96, (1963), pp. 184-187.
Database Crossfire, BRN=3274365, & Chem. BER., vol. 18, (1885) p. 3175.
Database Crossfire, BRN=3285701, & Chem. Ber., vol. 21, (1888), p. 3223.
Database Crossfire, BRN=3293381, & ZH Obshch. Khim., vol. 4(1934), pp. 728-731.
Database Crossfire, BRN=333,098, & J Amer. Chem. Soc., vol. 45, (1923), p. 1491.
Database Crossfire, BRN=3285692, & Rel. Trav. Chim Pays-Bas, vol. 24, (1905), p. 206.
Database Crossfire, BRN=387378, & HEM. Ber., vol. 86, (1953), p. 1073-1075.
Database Crossfire, BRN=1818729, & Chem. Ber., vol. 85, (1952), pp. 760-773.
Database Crossfire, BRN=1841461, & J. Amer. Chem. Soc., vol. 66, (1944), pp. 1851-1854.
Database Crossfire, BRN-514779, & Helv. Chim. Acta. vol. 17, (1934), pp. 1416-1417.
Database Crossfire, BRN=776989, & Am. Chem. J., vol. 37, (1907), p. 365.
Database Crossfire, BRN=32743303, & Chem Ber., vol. 18, (1885), p. 2193.
Database Crossfire, BRN=3283626, & Chem. Ber., vol. 18, p. 2193 (1885).
Database Crossfire, BRN=1818557, Indian J. Chem., vol. 1, (1953), p. 247-250.
Gully et al., "Biochemical and pharmacological profile a potent and selective nonpeptide antagonist of the nevrotonsin receptor," Proc. Natl. Acad. Sci. USA, 90, pp. 65-69 (Jan. 1993).
Boigegrain Robert
Gully Danielle
Jeanjean Francis
Labeeuw Bernard
Molimard Jean-Charles
Oswecki Jane C.
Richter Johann
Sanofi
LandOfFree
Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2247953